Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2019-06-19
2021-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?
NCT05837325
In Vitro Maturation of Immature Oocytes
NCT00480337
New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome
NCT03773263
Markers in Follicular Fluid and in Embryo Culture Medium as a Marker of Oocyte and Embryo Quality
NCT03350009
Human Follicular Fluid Markers and Reproductive Outcomes in IVF
NCT05893238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCOS follicular fluid
Raman spectrum
The wavelength of the follicular fluids were scaned by Raman spectrum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Raman spectrum
The wavelength of the follicular fluids were scaned by Raman spectrum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients under IVF cycles
Exclusion Criteria
* Patients with fallopian tube factors infertility
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ShangHai Ji Ai Genetics & IVF Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiaoxi Sun, Prof.
Role: STUDY_CHAIR
Shanghai JiAi Genetics & IVF Institute
Jing Fu, Dr.
Role: PRINCIPAL_INVESTIGATOR
Shanghai JiAi Genetics & IVF Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai JiAi Genetics and IVF Institute
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JIAI E2019-09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.